MDAI Overview

Spectral AI, Inc. is a predictive artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, with initial applications involving patients with burns. The Company's DeepView platform is a predictive device that offers clinicians an objective and immediate assessment of a wound healing potential prior to treatment or other medical intervention. DeepView platform that combines AI algorithms and multispectral imaging (MSI) imaging for an assessment of wound healing potential. It is non-invasive, non-radiation, non-laser and does not require the use of injectable dye. The DeepView AI- Burn software is used with the DeepView SnapShot imaging device, and it is intended to be used as an adjunctive tool to aid healthcare providers in the assessment of burn wound healing potential by differentiating non-healing from healing burned tissue within an image.

Wall Street analysts forecast MDAI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MDAI is4.50 USD with a low forecast of 3.00 USD and a high forecast of 6.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Spectral AI Inc revenue for the last quarter amounts to 4.09M USD, decreased -46.27

Spectral AI Inc. EPS for the last quarter amounts to 0.03 USD, decreased -107.69

Spectral AI Inc (MDAI) has 65 emplpoyees as of April 16 2026.

Today MDAI has the market capitalization of 60.78M USD.